Peizhi Luo
Vorstandsvorsitzender bei ADAGENE INC.
Vermögen: 22 Mio $ am 30.04.2024
Aktive Positionen von Peizhi Luo
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ADAGENE INC. | Vorstandsvorsitzender | 01.11.2011 | - |
| Vorsitzender | 01.02.2018 | - | |
| Technik-/Wissenschafts-/F&E-Leiter | - | - | |
| Gründer | 25.02.2011 | - |
Karriereverlauf von Peizhi Luo
Ehemalige bekannte Positionen von Peizhi Luo
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Abmaxis, Inc.
 Abmaxis, Inc. Pharmaceuticals: MajorHealth Technology Abmaxis Inc. develops pharmaceutical drugs. The company discovers and optimizes monoclonal antibody (mAb) products for human therapeutics and diagnostics. It has developed antibody engineering technology platform, Abmaxis in-silico Immunization (AISIM TM), which they are used for building an internal product pipeline and collaboration with global biotech and pharmaceutical partners. The company was founded in 2000 and is located in Santa Clara, CA. | Direktor/Vorstandsmitglied | 01.01.2000 | 06.11.2008 |
| Technik-/Wissenschafts-/F&E-Leiter | 01.01.2000 | 06.11.2008 | |
| Gründer | 01.01.2000 | 06.11.2008 | |
| Präsident | 01.01.2000 | 06.11.2008 | |
| XENCOR, INC. | Corporate Officer/Principal | 01.07.1998 | 01.08.2000 |
| MERCK & CO., INC. | Corporate Officer/Principal | - | - |
Ausbildung von Peizhi Luo
| The University of Chicago | Doctorate Degree |
| Peking University | Undergraduate Degree |
| Chinese Academy of Sciences | Graduate Degree |
Statistik
International
| Vereinigte Staaten | 5 |
| China | 4 |
Operativ
| Chief Tech/Sci/R&D Officer | 2 |
| Founder | 2 |
| Corporate Officer/Principal | 2 |
Sektoral
| Health Technology | 5 |
| Consumer Services | 4 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| ADAGENE INC. | Health Technology |
| XENCOR, INC. | Health Technology |
| MERCK & CO., INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Abmaxis, Inc.
Abmaxis, Inc. Pharmaceuticals: MajorHealth Technology Abmaxis Inc. develops pharmaceutical drugs. The company discovers and optimizes monoclonal antibody (mAb) products for human therapeutics and diagnostics. It has developed antibody engineering technology platform, Abmaxis in-silico Immunization (AISIM TM), which they are used for building an internal product pipeline and collaboration with global biotech and pharmaceutical partners. The company was founded in 2000 and is located in Santa Clara, CA. | Health Technology |
- Börse
- Insiders
- Peizhi Luo
- Erfahrung
